Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/132853
Campo DC Valoridioma
dc.contributor.authorGatica-Ortega, Maria E.en_US
dc.contributor.authorPastor-Nieto, Maria A.en_US
dc.contributor.authorGimenez-Arnau, Ana Mariaen_US
dc.contributor.authorMercader-Garcia, Pedroen_US
dc.contributor.authorSerra-Baldrich, Estheren_US
dc.contributor.authorZaragoza-Ninet, Violetaen_US
dc.contributor.authorSanz-Sanchez, Tatianaen_US
dc.contributor.authorSanchez-Gilo, Aracelien_US
dc.contributor.authorPesque, Daviden_US
dc.contributor.authorTous-Romero, Fatimaen_US
dc.contributor.authorOrtiz-de-Frutos, Francisco Javieren_US
dc.contributor.authorde la Rosa-Fernandez, Eduardoen_US
dc.contributor.authorDorta-Alom, Saraen_US
dc.contributor.authorElosua-Gonzalez, Martaen_US
dc.contributor.authorGonzalez-Perez, Ricardoen_US
dc.contributor.authorCarrascosa-Carrillo, Jose Manuelen_US
dc.contributor.authorMunera-Campos, Monicaen_US
dc.contributor.authorSilvestre-Salvador, Juan Franciscoen_US
dc.contributor.authorMiquel-Miquel, Javieren_US
dc.contributor.authorMinguez, Antonio de Mateoen_US
dc.contributor.authorBorrego Hernando, Leopoldoen_US
dc.date.accessioned2024-09-02T14:29:04Z-
dc.date.available2024-09-02T14:29:04Z-
dc.date.issued2024en_US
dc.identifier.issn0105-1873en_US
dc.identifier.otherWoS-
dc.identifier.urihttp://hdl.handle.net/10553/132853-
dc.description.abstractBackground: Reports of allergic contact dermatitis (ACD) to phytonadione epoxide (PE) in cosmetics suggest that PE is as powerful a sensitiser as its parent compound phytonadione. Objective: To evaluate a case series of ACD to PE in Spain. MethodsWe reviewed the records of 20 patients with ACD to cosmetics containing PE diagnosed across Spain between January 2019 and June 2023. Results: All 20 patients developed patch test (PT) or repeated open application test (ROAT) reactions to cosmetics containing PE. All involved women with eyelid eczema. PT or ROAT with PE preparations were positive in 17/20 (85%). PE at 1%, 5%, 10% and 20% in pet. was patch-tested in 8/17, 14/17, 11/17 and 8/17 patients; being positive in 6/8 (75%), 13/14 (92.85%), 11/11 (100%) and 8/8 (100%), respectively. Conclusion: Regulators should, not only ban the specific dangerous cosmetic ingredients, but also consider to ban or keep under close surveillance those closely related products or derivatives that might potentially cause similar harmful effects. PTs with PE are suggested to be performed at a 5% concentration in pet. Higher concentrations (10% pet.) should be tested whenever PTs with 5% pet. PE are negative.en_US
dc.languageengen_US
dc.relation.ispartofContact Dermatitisen_US
dc.sourceContact Dermatitis[ISSN 0105-1873], (2024)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320106 Dermatologíaen_US
dc.subject.otherAllergic Contact Dermatitisen_US
dc.subject.otherCas No 25486-55-9en_US
dc.subject.otherCosmeticsen_US
dc.subject.otherEpidemicen_US
dc.subject.otherEyelid Dermatitisen_US
dc.subject.otherPatch Testen_US
dc.subject.otherPhytonadioneen_US
dc.subject.otherPhytonadione Epoxideen_US
dc.subject.otherVitamin K1en_US
dc.subject.otherVitamin K1 Oxidiseden_US
dc.titleAn emerging epidemic of allergic contact dermatitis due to phytonadione epoxide (oxidised vitamin K1)en_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1111/cod.14675en_US
dc.identifier.isi001294560000001-
dc.identifier.eissn1600-0536-
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.description.notasOnline Version of Record before inclusion in an issueen_US
dc.description.numberofpages8en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Gatica-Ortega, ME-
dc.contributor.wosstandardWOS:Pastor-Nieto, MA-
dc.contributor.wosstandardWOS:Giménez-Arnau, AM-
dc.contributor.wosstandardWOS:Mercader-García, P-
dc.contributor.wosstandardWOS:Serra-Baldrich, E-
dc.contributor.wosstandardWOS:Zaragoza-Ninet, V-
dc.contributor.wosstandardWOS:Sanz-Sánchez, T-
dc.contributor.wosstandardWOS:Sánchez-Gilo, A-
dc.contributor.wosstandardWOS:Pesqué, D-
dc.contributor.wosstandardWOS:Tous-Romero, F-
dc.contributor.wosstandardWOS:Ortiz-de-Frutos, FJ-
dc.contributor.wosstandardWOS:de la Rosa-Fernández, E-
dc.contributor.wosstandardWOS:Dorta-Alom, S-
dc.contributor.wosstandardWOS:Elosua-González, M-
dc.contributor.wosstandardWOS:Gonzalez-Perez, R-
dc.contributor.wosstandardWOS:Carrascosa-Carrillo, JM-
dc.contributor.wosstandardWOS:Munera-Campos, M-
dc.contributor.wosstandardWOS:Silvestre-Salvador, JF-
dc.contributor.wosstandardWOS:Miquel-Miquel, J-
dc.contributor.wosstandardWOS:Minguez, AD-
dc.contributor.wosstandardWOS:Borrego, L-
dc.date.coverdate2024en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr0,681
dc.description.jcr5,5
dc.description.sjrqQ2
dc.description.jcrqQ1
dc.description.scieSCIE
dc.description.miaricds11,0
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-0199-2756-
crisitem.author.fullNameBorrego Hernando, Leopoldo-
Colección:Artículos
Adobe PDF (1,79 MB)
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.